Dr. Brian Clear, an addiction treatment physician and chief medical officer of Bicycle Health, believes that telemedicine is one way to improve access and reduce the inequities inherence in addiction treatment. The other is education.
Narcan, a nasal spray product that reverses the effects of opioid overdose, is now FDA approved for non-prescription use. Other recent FDA approvals include decisions for drugs from Pharming Group, Incyte, and Aurion Biotech.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Companies are developing non-drug approaches to tackling the prescription opioid crisis and stand to receive support from the likes of the NIH and the FDA.
With tens of thousands of American lives lost each year to drug overdose, it’s critical that we begin training Americans to administer Narcan (naloxone), just as we did with CPR, to help save the lives of our neighbors, family members and friends.
The opioid epidemic has become one of the largest healthcare priorities of the Trump Administration and one of the limited areas in the country's fractured political system where bipartisan support can be found.